Medicine & TechnologyA study reveals that adjuvant olaparib could help keep breast cancer at bay after initial treatment and help breast cancer patients live longer without the disease.
Staci Mishkin was tested for the BRCA breast cancer gene mutation eighteen years ago; at that time she was one of the first women in the US to do so. She had her breasts and ovaries removed to protect herself. Today she is 50 years old-the first woman in her family to live that long, and testing for the BRCA 1 and BRCA 2 gene mutations that cause breast cancer are the subject of intense debate.
In a new study published online in JAMA Oncology, researchers have discovered that the removal of the ovaries can reduce breast cancer death by 62 percent in women diagnosed with breast cancer and carrying a BRCA1 gene mutation.